![Sergio Traversa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sergio Traversa
Chief Executive Officer at
RELMADA THERAPEUTICS, INC.
Net worth: 9 M $ as of 31/05/2026
Profile
Sergio Traversa is currently Chief Executive Officer & Director at Relmada Therapeutics, Inc. since 2019.
Former roles include President, Chief Executive Officer, CFO & Director at Cactus Ventures, Inc. in 2013; Chief Executive Officer & Director at Camp Nine, Inc.; Chief Executive Officer at Relmada Therapeutics, Inc. from 2012 to 2013; Chief Executive Officer at Medeor, Inc. from 2010 to 2012; Independent Director at Actinium Pharmaceuticals, Inc. from 2014 to 2017; Director at Actinium Pharmaceuticals, Inc.; Managing Director at ING Barings LLC; Marketing Manager-Hospital Business Unit at Eli Lilly & Co.; Area Manager-Southern Europe at Therakos LLC; Principal at Farmitalia Carlo Erba SRL; Principal at Ardana Capital Management LP; Head-Sales at Farmitalia Carlo Erba Ltd. Education includes an undergraduate degree from the University of Turin and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/03/2026 | 1,300,000 ( 1.24% ) | 9 M $ | 31/05/2026 |
Sergio Traversa active positions
| Companies | Position | Start |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Executive Officer | 01/04/2012 |
Former positions of Sergio Traversa
| Companies | Position | End |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Chief Executive Officer | 16/09/2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Chief Executive Officer | 18/04/2013 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Director/Board Member | 18/04/2013 |
Medeor, Inc. | Chief Executive Officer | 01/04/2012 |
Farmitalia Carlo Erba Ltd. | Sales & Marketing | - |
Training of Sergio Traversa
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Therakos, Inc.
 Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
ING Barings LLC
 ING Barings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for the treatment of acute and chronic pains | Health Technology |
Farmitalia Carlo Erba SRL | Health Technology |
Ardana Capital Management LP
 Ardana Capital Management LP Investment ManagersFinance Ardana Capital Management manages a hedge fund that focuses on healthcare stocks | Finance |
University of Turin
 University of Turin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Medeor, Inc. | |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Farmitalia Carlo Erba Ltd. |
- Stock Market
- Insiders
- Sergio Traversa
